The UK government has been urged to speed up giving two doses of the covid-19 vaccine after data showed a single dose was only 33% effective against the B.1.617.2 variant first detected in India, which continues to see a rapid growth in cases in the UK. A preprint paper released by...
WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to h
The Miami Heraldreports on Johnson & Johnson’s single-dose COVID-19 vaccine, writing: The U.S. Food and Drug Administration released a report on Wednesday that says the one-dose Johnson & Johnson COVID-19 vaccine has a “favorable safety profile with no specific safety concerns,” clearing...
The Pfizer and Moderna vaccines use mRNA to carry the code to make the coronavirus spike protein, which allows the virus to invade human cells. The Johnson & Johnson vaccine uses DNA and a modified, weakened version of a cold virus to gain entry into human cells. It then triggers an immu...
J&J Says Its Single Dose Protects Against Breakthrough COVID-19 for up to 6 Months More Reuters FILE PHOTO: Vials labeled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 20...
A single dose of COVID-19 vaccine is sufficient for an infected person as there was a greater antibody response when compared with those who have had no prior infection, according to a study released by AIG Hospitals on Monday. The city-based AIG Hospitals recently published a study conducted...
BERLIN, May 24 (Xinhua) -- The German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI) on Tuesday extended its general COVID-19 vaccination recommendation to children between the ages of 5 and 11 with only one vaccine dose. ...
WASHINGTON (AP)-U.S. health advisers endorsed aone-dose COVID-19 vaccinefrom Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic. The Food and Drug Administration is expected to quickly follow the recommendation and mak...
The level of protection for the single-dose COVID-19 vaccine was 72% in the United States compared to 57% in South Africa at 28 days post-vaccination, suggesting lower efficacy against the emerging South African variant.
The company posted an interim analysis of its Phase I/IIa trial that showed a single dose of JNJ-78436735 induced a strong neutralizing antibody response in nearly all participants and was well-tolerated. Days after Johnson & Johnson moved its vaccine candidate into Phase III, the comp...